Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  M MUSCULO-SKELETAL SYSTEM
    M03 MUSCLE RELAXANTS
      M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
        M03BX Other centrally acting agents
          M03BX01 Baclofen
            D00241  Baclofen (JP18/USP/INN) <JP/US>

USP drug classification [BR:br08302]
  Antispasticity Agents
    Baclofen
      D00241  Baclofen (JP18/USP/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    12  Agents affecting peripheral nervous system
      124  Antispasmodics
        1249  Others
          D00241  Baclofen (JP18/USP/INN)

Drug groups [BR:br08330]
  Neuropsychiatric agent
    DG01565  GABA-B receptor agonist
      D00241  Baclofen
  Musculo-skeletal system agent
    DG02029  Muscle relaxant
      DG01974  Centrally acting muscle relaxant
        D00241  Baclofen

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Metabotropic glutamate receptor family
      GABA (metabotropic)
        GABBR [HSA:2550 9568] [KO:K04615]
          D00241  Baclofen (JP18/USP/INN) <JP/US>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D00241  Baclofen
    D00241  Baclofen tablets